| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a3febfbd930318f2b7418da1deddb9a |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2035-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0646
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0783
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| filingDate |
2018-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc0b6360336e3ff1a51ceff0db432081
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f43a18ee8dbd15ea227214f97ff024aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b0a4a2daebce23d574af8db32bacd02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b2b9dfec188bf54aeb6f8f3a0d48d5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_139e17179c58b14088fee41e53f76c0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a723adfe4b2679bbc8df006bee1561dc |
| publicationDate |
2019-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2019048809-A |
| titleOfInvention |
Placenta-derived natural killer cells |
| abstract |
The present invention provides a method of treating an individual having a tumor or graft versus host disease with specific natural killer cells. Kind Code: A1 A method using natural killer cells treated to remove a plurality of red blood cells from human placental perfusate fluid and cord blood and contacting isolated cells with an immunomodulatory compound. 【Selection chart】 None |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020189232-A1 |
| priorityDate |
2013-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |